Stockholm - Delayed Quote SEK

Integrum AB (publ) (INTEG-B.ST)

17.14
+0.16
+(0.94%)
At close: 5:23:25 PM GMT+2
Loading Chart for INTEG-B.ST
  • Previous Close 16.98
  • Open 17.04
  • Bid 16.84 x --
  • Ask 17.14 x --
  • Day's Range 16.78 - 17.74
  • 52 Week Range 12.48 - 61.40
  • Volume 31,707
  • Avg. Volume 47,059
  • Market Cap (intraday) 365.67M
  • Beta (5Y Monthly) 1.37
  • PE Ratio (TTM) --
  • EPS (TTM) -1.01
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 36.25

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.

www.integrum.se

36

Full Time Employees

April 30

Fiscal Year Ends

Recent News: INTEG-B.ST

View More

Performance Overview: INTEG-B.ST

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

INTEG-B.ST
6.34%
OMX Stockholm 30 Index (^OMX)
2.61%

1-Year Return

INTEG-B.ST
67.66%
OMX Stockholm 30 Index (^OMX)
3.18%

3-Year Return

INTEG-B.ST
60.82%
OMX Stockholm 30 Index (^OMX)
27.77%

5-Year Return

INTEG-B.ST
114.79%
OMX Stockholm 30 Index (^OMX)
63.70%

Compare To: INTEG-B.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INTEG-B.ST

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    362.26M

  • Enterprise Value

    352.85M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.71

  • Price/Book (mrq)

    2.23

  • Enterprise Value/Revenue

    3.92

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -20.24%

  • Return on Assets (ttm)

    -12.11%

  • Return on Equity (ttm)

    -13.00%

  • Revenue (ttm)

    97.31M

  • Net Income Avi to Common (ttm)

    -19.55M

  • Diluted EPS (ttm)

    -1.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.65M

  • Total Debt/Equity (mrq)

    3.23%

  • Levered Free Cash Flow (ttm)

    -47.55M

Research Analysis: INTEG-B.ST

View More

Company Insights: INTEG-B.ST

Research Reports: INTEG-B.ST

View More

People Also Watch